Vicenç Ruiz de Porras

17PUBLICATIONS
35CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersHaematological tumoursFood properties (incl. characteristics and health benefits)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Jul 15, 2026
Integrating the Neutrophil-to-Lymphocyte Ratio into a Clinicopathological Nomogram for Event-Free Survival Prediction in Cisplatin-Treated Muscle-Invasive Bladder Cancer.

|May 07, 2026
Overcoming T cell exhaustion and senescence in CAR T cell therapy for solid tumors.

|Jan 23, 2026
Oncopreventive and Oncotherapeutic Potential of Plant Secondary Metabolites Against Gastric Cancer: A Review.

Subhadas Chatterjee, Sankhadip Bose, Satarupa Acharjee

|Nov 27, 2025
YM155 Inhibition of Survivin Enhances Carboplatin Efficacy in Metastatic Castration-Resistant Prostate Cancer.

Vicenç Ruiz de Porras, Martin K Bakht, Maria Fernandez-Saorín

|Aug 14, 2025
Opioid Use in Cancer Pain Management: Navigating the Line Between Relief and Addiction.

Maite Trullols, Vicenç Ruiz de Porras

|Jul 12, 2025
Molecular Mechanisms of Tumor Progression and New Therapeutic Strategies for Urological Cancers, 2nd Edition.

Vicenç Ruiz de Porras

Pageof 3

Frequent Collaborators

5 joint publications

Mariona Figols

3 joint publications

Olatz Etxaniz

2 joint publications

Natalia Jiménez

2 joint publications

Begoña Mellado